Chinese General Practice ›› 2023, Vol. 26 ›› Issue (13): 1559-1567.DOI: 10.12114/j.issn.1007-9572.2022.W0002
Special Issue: 指南/共识最新文章合辑
• Chinese Clinical Practice Guidelines in Primary Care • Previous Articles Next Articles
Received:
2022-08-15
Revised:
2023-01-19
Published:
2023-05-05
Online:
2023-01-31
Contact:
YE Zhikang
通讯作者:
叶志康
作者简介:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2022.W0002
结局 | 强化降压组(%) | 常规降压组(%) | HR (95%CI) | 绝对风险差值(%) |
---|---|---|---|---|
复合心血管事件(卒中、急性冠脉综合征、急性心力衰竭、冠状动脉血管重建术、心房颤动、心血管死亡) | 3.5 | 4.6 | 0.74 (0.60,0.92) | 1.1 |
卒中 | 1.1 | 1.7 | 0.67 (0.47,0.97) | 0.6 |
急性冠脉综合征 | 1.3 | 1.9 | 0.67 (0.47,0.94) | 0.6 |
急性心力衰竭 | 0.1 | 0.3 | 0.27 (0.08,0.98) | 0.2 |
冠状动脉血管重建术 | 0.5 | 0.7 | 0.69 (0.40,1.18) | 0.2 |
心房颤动 | 0.6 | 0.6 | 0.96 (0.55,1.68) | 0 |
心血管死亡 | 0.4 | 0.6 | 0.72 (0.39,1.32) | 0.2 |
全因死亡 | 1.6 | 1.5 | 1.11 (0.78,1.56) | 0.1 |
Table 1 Effect of intensive and standard blood pressure lowering on cardiovascular events
结局 | 强化降压组(%) | 常规降压组(%) | HR (95%CI) | 绝对风险差值(%) |
---|---|---|---|---|
复合心血管事件(卒中、急性冠脉综合征、急性心力衰竭、冠状动脉血管重建术、心房颤动、心血管死亡) | 3.5 | 4.6 | 0.74 (0.60,0.92) | 1.1 |
卒中 | 1.1 | 1.7 | 0.67 (0.47,0.97) | 0.6 |
急性冠脉综合征 | 1.3 | 1.9 | 0.67 (0.47,0.94) | 0.6 |
急性心力衰竭 | 0.1 | 0.3 | 0.27 (0.08,0.98) | 0.2 |
冠状动脉血管重建术 | 0.5 | 0.7 | 0.69 (0.40,1.18) | 0.2 |
心房颤动 | 0.6 | 0.6 | 0.96 (0.55,1.68) | 0 |
心血管死亡 | 0.4 | 0.6 | 0.72 (0.39,1.32) | 0.2 |
全因死亡 | 1.6 | 1.5 | 1.11 (0.78,1.56) | 0.1 |
[1] |
|
[2] |
|
[3] |
Evidence-Based Medicine Working Group. Evidence-based medicine. A new approach to teaching the practice of medicine[J]. JAMA,1992,268(17):2420-2425. DOI:10.1001/jama.1992.0349=0170092032.
|
[4] |
|
[5] |
Canadian Institutes of Health Research. Knowledge translation in health care:moving from evidence to practice[EB/OL].(2015-11-18)[2022-07-22].
|
[6] |
|
[7] |
|
[8] |
World Health Organization. WHO handbook for guideline development,2nd edition[EB/OL]. (2014-12-18)[2022-07-28].
|
[9] |
MacGRADE Centre Coordination. GIN-McMaster guideline development checklist[EB/OL]. [2022-07-20].
|
[10] |
|
[11] |
|
[12] |
|
[13] |
|
[14] |
|
[15] |
国际实践指南注册与透明化平台[EB/OL].(2022-07-09)[2022-07-28].
|
[16] |
|
[17] |
|
[18] |
|
[19] |
Joint Committee for Guideline Revision. 2018 Chinese guidelines for prevention and treatment of hypertension:a report of the revision committee of Chinese guidelines for prevention and treatment of hypertension[J]. J Geriatr Cardiol,2019,16(3):182-241.DOI:10.11909/j.issn.1671-5411.2019.03.014.
|
[20] |
|
[21] |
|
[22] |
|
[23] |
|
[24] |
|
[25] |
|
[26] |
|
[27] |
|
[28] |
|
[29] |
|
[30] |
|
[31] |
|
[32] |
|
[33] |
|
[34] |
|
[35] |
|
[36] |
|
[37] |
|
[38] |
|
[39] |
|
[40] |
|
[41] |
ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention,detection,evaluation,and management of high blood pressure in adults:a report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines[J]. Hypertension,2018,71(6):e140-144. DOI:10.1161/hyp.0000000000000065.
|
[42] |
|
[43] |
|
[1] | MA Panpan, WANG Sijing, YOU Na, DING Dafa, LU Yibing. Efficacy and Safety of Danuglipron and Orforglipron in the Treatment of Type 2 Diabetes Mellitus: a Meta-analysis [J]. Chinese General Practice, 2025, 28(21): 2679-2685. |
[2] | MA Guifen, ZHANG Qian, SUN Jing. Interpretation of the Key Updates in the Latest Version of 2024 NCCN Clinical Practice Guidelines for Gastric Cancer [J]. Chinese General Practice, 2025, 28(14): 1681-1688. |
[3] | GAO Yicheng, YU Zijin, CAO Rui, LIU Zhihan, FANG Rui, LI Yuanyuan, DENG Yingjie, XIANG Wenyuan, FEI Yutong. Thinking and Methodological Suggestions of Empirical Research in the Development of Clinical Practice Guidelines [J]. Chinese General Practice, 2025, 28(04): 402-406. |
[4] | FENG Tianxiao, SUN Kai, QIN Xiaokuan, WANG Xu, BU Hanmei, ZHU Liguo, WEI Xu. Development Status, Challenges, and Strategies of Clinical Practice Guidelines in Traditional Chinese Medicine Orthopedics [J]. Chinese General Practice, 2024, 27(31): 3850-3856. |
[5] | HE Jingyi, WANG Fang, SHUI Xiaoling, LI Ling, LIANG Qian. Efficacy of Non-pharmacological Interventions to Improve Perimenopausal Insomnia Symptoms: a Network Meta-analysis [J]. Chinese General Practice, 2023, 26(31): 3963-3974. |
[6] | SU Guobin, LING Xitao, DUAN Ruolan, ZHANG La, XU Yuan, PENG Yu, HOU Haijing, LIU Xusheng, LU Fuhua. Selection of Therapeutic Drugs for COVID-19 Infection in Adults with Chronic Kidney Disease Based on Medical Evidence [J]. Chinese General Practice, 2023, 26(26): 3220-3229. |
[7] | LIU Jingtao, SU He, QIN Xiaojin, LAN Yunxia, ZHANG Jinzhi. Guidelines on Cardiac Rehabilitation in Patients with Coronary Heart Disease: a Systematic Review [J]. Chinese General Practice, 2023, 26(19): 2323-2331. |
[8] | ZHA Qianqian, XU Lianying, CHEN Juan, HUANG Wen, ZHANG Xinqiong. Summary of Best Evidence for Prevention of Recurrence of Late-life Depression [J]. Chinese General Practice, 2023, 26(19): 2332-2338. |
[9] | LIU Xiao, ZHANG Jinying, PENG Yan, WANG Li, CHEN Xiaomei, LIU Jia, DENG Menghui, YANG Yanni. Summary of the Best Evidence for Dietary Nutrients Management to Promote Brain Health in Community-dwelling Residents [J]. Chinese General Practice, 2023, 26(13): 1568-1576. |
[10] | LUO Yachan, KONG Lingna, LYU Qiong, YAO Haiyan. Prevalence and Associated Factors of Potentially Inappropriate Medication in Community-dwelling Older Adults in China: a Meta-analysis [J]. Chinese General Practice, 2023, 26(13): 1605-1612. |
[11] | WANG Ping, WU Shouyuan, SUN Yajia, LAN Hui, REN Mengjuan, ZHAO Junxian, WANG Ling, SU Renfeng, ZHOU Qi, WANG Zijun, WANG Qi, MA Li, HOU Tianchun, CHEN Yaolong. Current Situation Analysis and Quality Evaluation of Chinese Clinical Practice Guidelines in General Practice [J]. Chinese General Practice, 2023, 26(13): 1551-1558. |
[12] | WANG Xixi, SHEN Rui, WANG Junjie, XU Niying. Best Evidence Summary of Exercise Interventions for Osteoporosis in Postmenopausal Women [J]. Chinese General Practice, 2023, 26(09): 1151-1158. |
[13] | YANG Hui, XU Yanli, YE Zhikang. Development, Application and Effectiveness of Clinical Guidelines in General Practice [J]. Chinese General Practice, 2023, 26(01): 1-10. |
[14] | TIAN Xintong, MA Teng, SUN Xuan, YANG Ji, ZHAO Yingqiang. Clinical Guidelines Analysis and Quality Assessment of Guidelines for Hypertension in the Elderly [J]. Chinese General Practice, 2022, 25(34): 4259-4266,4285. |
[15] | HE Ting, YUAN Li, YANG Xiaoling, YE Ziwei, LI Rao, GU Yan. Risk Prediction Models for Type 2 Diabetes in Asian Adults: a Systematic Review [J]. Chinese General Practice, 2022, 25(34): 4267-4277. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||